用于α和β粒子发射体定量单粒子数字放射自显影的辐射成像仪
综述指出靶向α和β发射体放疗缺乏细胞水平生物分布与剂量-反应信息,传统放射自显影、闪烁显像和SPECT/CT因分辨率差、测量时间长、空间分辨率低而无法有效评估细胞水平吸收剂量分布。新数字放射自显影工具基于闪烁、气体和半导体探测技术,可逐事件定位带电粒子发射位置,α和β发射体分辨率可达20 µm FWHM,活度浓度可定量至mBq/µg,并支持实时和同时成像高/低活度样品。
要点
- 传统放射自显影、闪烁显像和SPECT/CT分辨率差、测量时间长、空间分辨率低,信噪比不佳。
- 新数字放射自显影工具对α和β发射体分辨率可达20 µm FWHM,活度浓度定量至mBq/µg。
- 新系统支持实时成像和同时成像高/低活度样品,无传统放射自显影的动态范围限制。
核心结论
- 新数字放射自显影成像工具有望解决细胞水平剂量分布评估的挑战,帮助优化靶向、达到所需治疗剂量并评估正常器官和组织安全性。
研究设计与样本
- 本文为综述,回顾各类探测器及其相关性能权衡,为研究人员选择最优探测器配置以满足成像需求提供当前技术概览。
主要发现
- 闪烁、气体和半导体基辐射探测技术可逐事件定位带电粒子发射位置,α和β发射体分辨率可达20 µm FWHM。
- 这些成像系统可将放射性核素活度浓度定量至mBq/µg,并提供实时成像及同时成像高活度和低活度样品的能力。
- 大面积成像仪可获取(>20 × 20 cm²),以适应高通量成像研究。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Promising therapies are being developed or are in early-stage clinical trials that employ the use of alpha- and beta-emitting radionuclides to cure hematologic malignancies. However, these targeted radionuclide therapies have not yet met their expected potential for cancer treatment. A primary reason is lack of biodistribution, dosimetry, and dose-response information at cellular levels, which are directly related to optimal targeting, achieving a requisite therapeutic dose, and assessing the safety profile in normal organs and tissues. The current set of imaging tools, such as film autoradiography, scintigraphy, and SPECT/CT, available to researchers and clinicians do not allow the effective assessment of radiation absorbed dose distributions at cellular levels because resolutions are poor, measurement and analytical times are long, and the spatial resolutions are low-generally resulting in poor signal-to-noise ratios. Recently, new radiation digital autoradiography imaging tools have been developed that promise to address these challenges. They include scintillation-, gaseous-, and semiconductor-based radiation-detection technologies that localize the emission location of charged particles on an event-by-event basis at resolutions up to 20 µm FWHM for alpha and beta emitters. These imaging systems allow radionuclide activity concentrations to be quantified to unprecedented levels (mBq/µg) and provide real-time imaging and simultaneous imaging capabilities of both high- and low-activity samples without dynamic range limitations that plague traditional autoradiography. Additionally, large-area imagers are available (>20 × 20 cm2) to accommodate high-throughput imaging studies. This article reviews the various detector classes and their associated performance trade-offs to provide researchers with an overview of the current technologies available for selecting an optimal detector configuration to meet imaging requirement needs.
引用
- Miller BW. Radiation Imagers for Quantitative, Single-particle Digital Autoradiography of Alpha- and Beta-particle Emitters. Semin Nucl Med. 2018. PMID: 29852946. doi:10.1053/j.semnuclmed.2018.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。